Evidence of health treatments efficacy
Examples
Evidence of Health Treatment Efficacy Implementation Guide published by Linca Telecomunicações Ltda. This guide is not an authorized publication; it is the continuous build for version 1.0.0. This version is based on the current content of <link> and changes regularly. See the implementation guide for version fhir r5
Examples
Page standards status: Informative
Evidence
{
"resourceType": "Evidence",
"id": "12",
"meta": {
"versionId": "2",
"lastUpdated": "2026-05-12T10:53:35.904-03:00"
},
"extension": [
{
"url": "https://treatments.telix.health/implementationguide/extensions/study-country",
"valueCodeableConcept": {
"coding": [
{
"system": "https://hl7.org/fhir/ValueSet/country",
"code": "CN",
"display": "China"
}
]
}
}
],
"identifier": [
{
"use": "official",
"system": "https://interneb.org/global-computable-evidence-identifiers",
"value": "osteoarthritis-artrodar-pmc9908446"
}
],
"title": "This Evidence resource describes a clinical study evaluating diacerein-based treatment for knee osteoarthritis.",
"status": "active",
"date": "2023-01",
"publisher": "Linca Telecomunicações Ltda",
"author": [
{
"name": "Diuary Cordeiro Machado",
"telecom": [
{
"system": "email",
"value": "diuarycm@gmail.com"
}
]
}
],
"useContext": [
{
"code": {
"system": "https://build.fhir.org/ig/HL7/ebm/en/ValueSet-179431.html",
"code": "population",
"display": "Population"
},
"valueCodeableConcept": {
"coding": [
{
"system": "https://icd.who.int/ct/icd11_mms/en",
"version": "2026-01",
"code": "FA01",
"display": "Osteoarthritis"
}
]
}
},
{
"code": {
"system": "https://build.fhir.org/ig/HL7/ebm/en/ValueSet-179431.html",
"code": "intervention",
"display": "Intervention"
},
"valueCodeableConcept": {
"coding": [
{
"system": "https://www.gs1.org/industries/healthcare",
"code": "7896281152018",
"display": "Artrodar 50 mg, 30 capsules, Brazil"
}
]
}
},
{
"code": {
"system": "https://build.fhir.org/ig/HL7/ebm/en/ValueSet-179431.html",
"code": "outcome-measure",
"display": "Outcome Measure"
},
"valueCodeableConcept": {
"coding": [
{
"system": "https://terminology.hl7.org/7.1.0/en/ValueSet-research-study-purpose-type.html",
"code": "efficacy",
"display": "Efficacy Study"
}
]
}
}
],
"relatedArtifact": [
{
"type": "citation",
"display": "Zhiyu Wang et al. American Journal of Translational Research, 01 / 2023",
"document": {
"url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9908446/",
"title": "Diacerein plus glucosamine hydrochloride improves the safety and efficacy and inhibit inflammatory factors in the treatment of knee osteoarthritis"
}
}
],
"variableDefinition": [
{
"description": "Efficacy is calculated as the number of people who had a specific benefit from the treatment divided by the number of people who used or underwent the treatment. The specific benefits are categorized as the code system below.",
"variableRole": {
"coding": [
{
"system": "https://www.hl7.org/fhir/valueset-variable-role.html",
"code": "measuredVariable",
"display": "Measured Variable"
}
]
}
}
],
"studyDesign": [
{
"coding": [
{
"system": "https://hl7.org/fhir/codesystem-study-design.html",
"code": "SEVCO:010013",
"display": "Case-control studies"
}
]
}
],
"statistic": [
{
"description": "Efficacy calculated based on patients who achieved a persistent reduction in the intensity, frequency, or variety of symptoms with the use of the treatment.",
"category": {
"coding": [
{
"system": "https://treatments.telix.health/codesystem/categorized-efficacy-outcomes",
"code": "persistent-reduction",
"display": "Persistent reduction of symptoms/indicators"
}
]
},
"numberOfEvents": 55,
"numberAffected": 35,
"sampleSize": {
"numberOfParticipants": 116
}
}
]
}
Telix Implementation Guide - 2026 - Linca Telecomunicações